Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Today in the News.
Press releases published on April 30, 2025

Ceribell to Participate in the Bank of America Securities 2025 Health Care Conference
SUNNYVALE, Calif., April 30, 2025 (GLOBE NEWSWIRE) -- CeriBell, Inc. (Nasdaq: CBLL) (“Ceribell”), a medical technology company focused on transforming the diagnosis and management of patients with serious neurological conditions, today announced that Jane …

Terns Pharmaceuticals to Participate in The Citizens Life Sciences Conference
FOSTER CITY, Calif., April 30, 2025 (GLOBE NEWSWIRE) -- Terns Pharmaceuticals, Inc. (“Terns” or the “Company”) (Nasdaq: TERN), a clinical-stage biopharmaceutical company developing a portfolio of small-molecule product candidates to address serious …

Codexis to Report First Quarter 2025 Financial Results on May 14
REDWOOD CITY, Calif., April 30, 2025 (GLOBE NEWSWIRE) -- Codexis, Inc. (NASDAQ: CDXS), a leading provider of enzymatic solutions for efficient and scalable therapeutics manufacturing, today announced that it will report its financial results for the first …

Fossil Group, Inc. Announces Date for First Quarter 2025 Earnings Release and Conference Call
RICHARDSON, Texas, April 30, 2025 (GLOBE NEWSWIRE) -- Fossil Group, Inc. (NASDAQ: FOSL) announced today that it will report first quarter 2025 financial results after market close on Wednesday, May 14, 2025, followed by a conference call to discuss the …

RxSight, Inc. to Present at the Bank of America Healthcare Conference
ALISO VIEJO, Calif., April 30, 2025 (GLOBE NEWSWIRE) -- (NASDAQ: RXST) -- RxSight, Inc., an ophthalmic medical device company dedicated to providing high-quality customized vision to patients following cataract surgery, today announced plans to participate …

SEALSQ Announces Agenda of its 2025 Annual General Meeting of Shareholders
Geneva, Switzerland, April 30, 2025 (GLOBE NEWSWIRE) -- SEALSQ Corp (“SEALSQ” or “the Company”) (NASDAQ: LAES), a company that focuses on developing and selling Semiconductors, PKI, and Post-Quantum technology hardware and software products, is pleased to …

Vaxart to Present at the Citizens Life Sciences Conference
SOUTH SAN FRANCISCO, Calif., April 30, 2025 (GLOBE NEWSWIRE) -- Vaxart, Inc. (NASDAQ: VXRT) today announced that members of the management team will present at the Citizens Life Sciences conference taking place May 7-8, 2025. Presentation Details: Date and …

Robinhood Reports First Quarter 2025 Results
Revenues up 50% year-over-year to $927 million Net Deposits grow to a record $18.0 billion, and Robinhood Gold Subscribers reached a record 3.2 million Net Income up 114% year-over-year to $336 million Diluted EPS up 106% year-over-year to $0.37 Board …

Cipher Mining Announces Date of First Quarter 2025 Business Update Conference Call
NEW YORK, April 30, 2025 (GLOBE NEWSWIRE) -- Cipher Mining Inc. (NASDAQ: CIFR) (“Cipher” or the “Company”) today announced it will provide a business update and release its first quarter 2025 financial results before U.S. markets open on Tuesday, May 6, …

Iridex to Report First Quarter 2025 Financial Results on May 13, 2025
MOUNTAIN VIEW, Calif., April 30, 2025 (GLOBE NEWSWIRE) -- Iridex Corporation (Nasdaq: IRIX), a worldwide leader providing innovative and versatile laser-based medical systems, delivery devices, and procedure probes for the treatment of glaucoma and retinal …

MediaAlpha Announces First Quarter 2025 Financial Results
Exceeds First Quarter Guidance with Revenue Growth of 109% and Transaction Value Growth of 116%; Delivers Record Transaction Value of $407 million in Property & Casualty Vertical First Quarter Net Loss of $(2.3) million; Adjusted EBITDA(1)of $29.4 million …

Credit Acceptance Announces First Quarter 2025 Results
Southfield, Michigan, April 30, 2025 (GLOBE NEWSWIRE) -- Credit Acceptance Corporation (Nasdaq: CACC) (referred to as the “Company”, “Credit Acceptance”, “we”, “our”, or “us”) today announced consolidated net income of $106.3 million, or $8.66 per diluted …

Hudbay Completes Transaction to Consolidate 100% Ownership in the Copper Mountain Mine
TORONTO, April 30, 2025 (GLOBE NEWSWIRE) -- Hudbay Minerals Inc. (“Hudbay” or the “Company”) (TSX, NYSE: HBM) is pleased to announce the completion of the previously announced acquisition of Mitsubishi Materials Corporation’s (“MMC”) 25% interest in Copper …

Sun Communities, Inc. Completes Sale of Safe Harbor Marinas to Blackstone Infrastructure
Southfield, MI, April 30, 2025 (GLOBE NEWSWIRE) -- Sun Communities, Inc. (NYSE: SUI) (the "Company" or “Sun”), a real estate investment trust (“REIT”) that owns and operates or has an interest in manufactured housing (MH) and recreational vehicle (RV) …

Sezzle to Hold an Annual Shareholder Meeting, Report 1Q25 Results, and Attend Investor Conferences
Minneapolis, MN, April 30, 2025 (GLOBE NEWSWIRE) -- Sezzle Inc. (NASDAQ: SEZL) (Sezzle or Company) // Purpose-driven digital payment platform, Sezzle, has scheduled its 2025 Annual Meeting of Stockholders for June 10, 2025, at 5:00 pm ET. The meeting will …

Mdxhealth to Release First Quarter 2025 Financial Results on May 14
Company to Host Conference Call with Live Q…

Information relative au nombre total de droits de vote et d’actions composant le capital social au 11 avril 2025
Article R. 22-10-23 du Code de commerce Place de cotation : Euronext Paris Code ISIN / Mnémo : FR0013233012 / IVA Site web : www.inventivapharma.com Date Nombre de titres composant le capital en circulation Nombre total de droits de vote bruts(1) …

Statement of total voting rights and shares forming the company’s share capital as of April 11, 2025
Article R. 22-10-23 of the French Commercial Code Market: Euronext Paris ISIN code / Mnemo: FR0013233012 / IVA Web site: www.inventivapharma.com Date Number of shares outstanding Total voting rights, gross (1) Total voting rights, net (2) April 11, 2025 95 …

Combined General Meeting of May 22, 2025 - Availability of the preparatory documents
Daix (France), New York City (New York, United States), April 30, 2025 – Inventiva (Euronext Paris and Nasdaq: IVA), a clinical-stage biopharmaceutical company focused on the development of oral small molecule therapies for the treatment of metabolic …

Assemblée Générale Mixte du 22 mai 2025 - Modalités de mise à disposition des documents préparatoires
Daix (France), New York City (New York, Etats-Unis), le 30 avril 2025 – Inventiva (Euronext Paris et NASDAQ : IVA) (« Inventiva » ou la « Société »), société biopharmaceutique spécialisée dans le développement clinique de petites molécules administrées par …